Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pancreatic Neoplasms × Fluorouracil × Clear all

Phase

Phase 2 70 Phase 3 28 Phase 1 26 Phase 1/2 23 Phase 2/3 5 Phase NA 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Uterine Cervical Dysplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neuritis 1 Mucositis 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Gemcitabine 5 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 palbociclib 2 olaparib 2 cobimetinib 2 Surgical Procedures, Operative 2 Radiosurgery 2 Positron-Emission Tomography 2 Oxaliplatin 2 Oncolytic Virotherapy 2 Nivolumab 2 Ketamine 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Disulfides 2 Cyclophosphamide 2 Biopsy 2 tremelimumab 1 trastuzumab biosimilar HLX02 1 toripalimab 1 sonidegib 1 pimonidazole 1 pertuzumab 1 pembrolizumab 1 paricalcitol 1 onvansertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01992705 2019-08-19

GCC 1324

University of Maryland, Baltimore

Phase EARLY_PHASE1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡